influence drug interval effect methotrexate fluorouracil treatment advanced colorectal cancer importance interval methotrexate MTX fluorouracil patients measurable advanced colorectal cancer MTX hours hour arm MTX patients leucovorin LV hours MTX hours doses regimen weeks escalation arm respect overall response rate time progression TTP median months months survival median months months Significant differences arms response rate median TTP median survival subgroup patients rectal primaries patients arm Significant factors prognostic survival performance status number metastases treatment Age survival Toxicity similar arms gastrointestinal mucositis arm toxic deaths secondary infection arm arm deaths arm arm drug-related combination MTX LV rescue active regimen advanced colorectal cancer efficacy colon rectal cancer interval MTX long hours short hour 